STE · News · 20260805N

Headcount / Restructuring

STERIS plc · 2026-08-05 · Importance 46 · Surprise 42 · In source text

STERIS is consolidating formulated chemistries manufacturing and distribution into the new North Carolina Center of Excellence. The plan is expected to close facilities in St. Louis, Missouri, and Plymouth, Minnesota, by March 31, 2027. STERIS expects total pre-tax restructuring charges of $55 million to $70 million through fiscal 2030, with $25 million to $30 million associated with the two facility closures and approximately $5 million to $7 million of that closure-related amount expected to be cash costs. The restructuring will increase capital expenditures and modestly reduce projected free cash flow while most charges are expected to be non-cash.

Key facts

• STERIS expects to close chemistry manufacturing and distribution facilities in St. Louis and Plymouth, Minn., by March 31, 2027. source
• STERIS expects to incur total pre-tax restructuring charges of about $55 million to $70 million related to consolidating formulated chemistries manufacturing into the North Carolina Center of Excellence. source
• STERIS anticipates incurring pre-tax charges of $25 million to $30 million over the next three fiscal years for the St. Louis and Plymouth closures, with a cash component of $5 million to $7 million. source
• STERIS said the majority of the expected total pre-tax restructuring charges of $55M-$70M are expected to be non-cash. source
• Bank of America Corp DE sold 399,568 shares of STERIS plc. source

Impact estimates